Showing of 3 results
Clinical Trial for ARDS in COVID-19 Patients
UH Research & Education Update | July 2020
Athersys and UH announce activation of first clinical site for MACOVIA study, a pivotal Phase 2/3 study evaluating Multistem® cell therapy for COVID-19 induced ARDS
UH Cleveland Medical Center, a nationally ranked hospital, is ready to start screening patients - News Release
Clinical Trial Seeks Potential ARDS Treatment
MultiStem® Therapy in Acute Respiratory Distress Syndrome shows promising early results - Innovations in Pulmonology and Sleep Medicine | Summer 2019
Results are loading...